Shionogi & Co., Ltd.

4507.T
Drug Manufacturers - Specialty & Generic
2026/11/11 12:12 Updated
Market Cap: $16.5B (¥2.6T)
Stock Price: $19.43 (¥3,080)
Exchange Rate: 1 USD = ¥158.48

Correction: Financial Summary for the Six-Month Period Ended March 2027 (IFRS, Consolidated) – Correction Notice

Published corrections to parts of the financial summary for the six-month period ended March 2027. Corrections relate to cash flow figures and adjustments to the calculation of dividends received from equity-method affiliates. Key financial items, including the balance and change in cash and cash equivalents, have been updated after correction.

Importance:
Page Updated: November 11, 2026
IR Disclosure Date: November 11, 2026

Key Figures

  • Cash and cash equivalents at the end of the interim period: 376,482 yen
  • Cash flows from operating activities: 107,257 yen
  • Dividends received from equity-method affiliates: 31,192 yen

AI要約

Summary of Corrections

Shionogi & Co., Ltd. announced that certain figures in the consolidated interim financial summary for the six-month period ended March 2027 (IFRS) contained errors related to cash flow items and portions of the condensed financial statements. The corrections include errors in the interim cash flow calculations and the computation process for dividends received from equity-method affiliates, and the corrected figures have been disclosed.

Impact on Financials and Outlook

Following the corrections, cash flows from operating activities and the balance of cash and cash equivalents at the interim period end have been adjusted, which also affects cash flows from investing and financing activities. The correction to the amount of dividends received from equity-method affiliates may affect the notes to the financial statements, and careful attention is required when assessing financial health.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Shionogi & Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →